AKR1B10 and colorectal cancer: An increased AKR1B10 expression was associated with a poorer prognosis in oral squamous cells, gastric carcinomas, and lung adenocarcinomas [39,41,50,51] whereas a decreased AKR1B10 expression was associated with a significantly worse survival in colorectal cancer [52].